Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should…mehr
This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials. The author suggests that CMC (chemistry manufacturing controls) drug development must reset the line of sight - from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. Capable processes and suppliers, streamlined logistics, flexible plant and equipment, shorter cycle times, effective flow of information and reduced waste. All these factors can and should be addressed at the CMC development stage.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in D ausgeliefert werden.
Hedley Rees runs the independent consulting company Biotech PharmaFlow, which specializes in pharmaceutical supply chain management. He has been actively building, managing, and continuously improving supply chains in biotech for the last fifteen years.
Inhaltsangabe
CONTRIBUTORS xiii PREFACE xxi I SURVEYING AND MAPPING THE TERRITORY 1 1 Setting a Transformational Agenda 3 1.1 Aims and Aspirations of the Book 3 1.2 Book Format 5 1.3 Intended Readership 6 1.4 A Book About Two Worlds in Contrast 8 1.5 The Pharmaceutical Lottery 8 1.6 Supply Chain Management in Context 17 1.7 The History of Supply and Value Generation 22 1.8 The Development of Processes to Manage the Supply Chain 24 1.9 Life in SCM 25 1.10 Moving Forward 26 2 Plotting a Course to Patient Value 29 2.1 Why Focus on Patient Value? 29 2.2 Where Does the Patient Currently Fit? 29 2.3 Why Is It Necessary to Plot a Course? 33 2.4 Understanding How the Course Is Presently Set 39 2.5 Capturing Value for Patients 42 3 Pharmaceutical Drug Development 45 3.1 Drug Development's Role in the Supply Chain 45 3.2 Introduction to Drug Development 47 3.3 The Medicinal Product 48 3.4 Clinical Trials 49 3.5 Related Development Programs 52 3.6 Managing Clinical Programs 57 3.7 Regulatory Affairs and Authorities 58 3.8 Supply Chain Management in Development Programs 65 3.9 Manufacture and Supply of Commercial Products 68 3.10 Supply Chain Management for Commercial Products 69 4 End-to-End Pharmaceutical Supply Chains 73 4.1 Introduction 73 4.2 Where Does Responsibility for the Supply Chain Lay? 74 4.3 Sponsoring Companies, License Holders, and Their Supply Chains 75 4.4 Supply Chains for Small-Molecule Products 76 4.5 Starting at the Final Destination 78 4.6 How Drugs Enter the Body 78 4.7 Design of Drug Delivery Systems 79 4.8 What This Means for the Supply Chain 82 4.9 Key Aspects of GMP and GDP in Relation to SCM 82 4.10 Overview of the Stages on Route to Patient Delivery 86 4.11 Manufacture and Supply of Biological Entities 90 5 Why Pharma Supply Chains Don't Perform 103 5.1 Supply Chain Underperformance 103 5.2 Is There a Case to Answer? 103 5.3 Birth to Infancy: The Supply Chain Critical Stage 104 5.4 Commercial Supply Under the Patent Protection Umbrella 111 5.5 What This Means for the Pharmaceutical Supply Chain 116 II BUILDING A KNOWLEDGE FOUNDATION IN SCM 125 6 Supply Chain Management as a Competitive Weapon 127 6.1 Competition and Business Strategy 127 6.2 The Marketing Mix 128 6.3 Porter's Five Forces 128 6.4 Porter's Generic Competitive Strategies 129 6.5 Porter's Value Chain 129 6.6 Competitive Strategy and Customers 133 6.7 The Japanese Experience 142 6.8 Total Quality Management 142 6.9 Lean Thinking 143 6.10 Focusing on Value for Money 146 6.11 SCM Processes in Competitive Strategy 148 6.12 SCM in Biotech and Virtual Companies 150 6.13 Competition in Pharmaceuticals 152 7 Supply Chain Management Holistic 155 7.1 The Relevance of SCM to Pharmaceuticals 155 7.2 Production Systems and the SCM Holistic 155 7.3 The Core of SCM 156 7.4 First Principle of SCM 156 7.5 Supply Chains as a Series of Interconnected Systems 158 7.6 Processes to Manage the Supply Chain 160 7.7 A Word About Processes 161 7.8 How the SCM Processes Should Mesh Together 163 7.9 Production and Inventory Control 163 7.10 Strategic Procurement 163 7.11 Transportation, Storage, and Distribution 164 7.12 Information Systems and Technology 164 7.13 Improvement 165 8 Production and Inventory Control 167 8.1 Core Mission 167 8.2 First Principles of Production and Inventory Control 167 8.3 The Wholesome Trinity in P&IC 174 8.4 The Wholesome Trinity and Customer Expectations 177 8.5 Leveraging the Wholesome Trinity 179 8.6 The Impact of Variety on Supply Chains 180 8.7 Designing Appropriate Production Systems 183 9 Strategic Procurement 187 9.1 Core Mission 187 9.2 The Purchasing Portfolio 188 9.3 The Process of Procurement 195 9.4 Strategic Sourcing and Planning 198 9.5 Outsourcing 201 9.6 Basic Principles in Contracting for Supply 206 9.7 Finally, Typical Organizational Tension over Procurement 213 10 Transportation, Storage, and Distribution 215 10.1 Defining the Core Mission 215 10.2 International Trade and Commerce 217 10.3 The World Trade Organization 217 10.4 Intermediary Arrangements 220 10.5 Terms of Trade: Incoterms 223 10.6 Ownership of Goods: Title 225 10.7 Third-Party Logistics Providers 226 10.8 Customs 227 10.9 Shipping Regulations Relating to Materials 229 10.10 A Finishing Note 230 11 Information Systems and Information Technology 233 11.1 Overview 233 11.2 Brief Lay History of Computer Systems Development 234 11.3 Important Perspectives on Information Systems 236 12 Improvement 255 12.1 Why Improve? 255 12.2 Improvement and Production Systems 257 12.3 The Improvement Journey 258 13 Bringing the Holistic Together 277 13.1 Setting the Scene 277 13.2 The Process Explained 278 13.3 Developing an Action Agenda 285 13.4 Case Study 289 III PLANNING AND EXECUTING SUPPLY CHAIN CHANGE 293 14 Improvement in Pharmaceuticals 295 14.1 Where Are We Now? 295 14.2 Subsequent Developments Since Inception 310 14.3 A Blueprint for Quality by Design 311 15 Exemplar Thinking in Organizational Improvement 335 15.1 Where Are We Now? 335 15.2 What Is Meant by "Exemplar"? 338 15.3 A Dialogue on Exemplar Improvement 338 15.4 An Approach to SCM Based on Systems Thinking 357 16 Building a Foundation for Sustainable Change 363 16.1 Focus on the Individual 363 16.2 Individuals as Leaders 368 16.3 Individuals as Motivators and the Motivated 370 16.4 Individuals as Group Members 372 16.5 Individuals as Participants in Cultural Change 376 16.6 Case Study: Miles Ltd., Bridgend, Glamorgan 378 17 A Cure for the Pharmaceutical Supply Chain 395 17.1 What Is the Disease State? 395 17.2 What Is the Label Claim for the Medicine? 396 17.3 What Will Life Hold Without the Medicine? 397 17.4 What Is This Better Way to Develop Drugs? 397 17.5 Full-Scale Production of Drugs 407 17.6 What Are the Barriers to Change? 410 17.7 What Are the Potential Benefits of Change? 413 17.8 Defining the Art of the Possible 414 17.9 Ending with the Beginning 417 END NOTES 419 INDEX 429
CONTRIBUTORS xiii PREFACE xxi I SURVEYING AND MAPPING THE TERRITORY 1 1 Setting a Transformational Agenda 3 1.1 Aims and Aspirations of the Book 3 1.2 Book Format 5 1.3 Intended Readership 6 1.4 A Book About Two Worlds in Contrast 8 1.5 The Pharmaceutical Lottery 8 1.6 Supply Chain Management in Context 17 1.7 The History of Supply and Value Generation 22 1.8 The Development of Processes to Manage the Supply Chain 24 1.9 Life in SCM 25 1.10 Moving Forward 26 2 Plotting a Course to Patient Value 29 2.1 Why Focus on Patient Value? 29 2.2 Where Does the Patient Currently Fit? 29 2.3 Why Is It Necessary to Plot a Course? 33 2.4 Understanding How the Course Is Presently Set 39 2.5 Capturing Value for Patients 42 3 Pharmaceutical Drug Development 45 3.1 Drug Development's Role in the Supply Chain 45 3.2 Introduction to Drug Development 47 3.3 The Medicinal Product 48 3.4 Clinical Trials 49 3.5 Related Development Programs 52 3.6 Managing Clinical Programs 57 3.7 Regulatory Affairs and Authorities 58 3.8 Supply Chain Management in Development Programs 65 3.9 Manufacture and Supply of Commercial Products 68 3.10 Supply Chain Management for Commercial Products 69 4 End-to-End Pharmaceutical Supply Chains 73 4.1 Introduction 73 4.2 Where Does Responsibility for the Supply Chain Lay? 74 4.3 Sponsoring Companies, License Holders, and Their Supply Chains 75 4.4 Supply Chains for Small-Molecule Products 76 4.5 Starting at the Final Destination 78 4.6 How Drugs Enter the Body 78 4.7 Design of Drug Delivery Systems 79 4.8 What This Means for the Supply Chain 82 4.9 Key Aspects of GMP and GDP in Relation to SCM 82 4.10 Overview of the Stages on Route to Patient Delivery 86 4.11 Manufacture and Supply of Biological Entities 90 5 Why Pharma Supply Chains Don't Perform 103 5.1 Supply Chain Underperformance 103 5.2 Is There a Case to Answer? 103 5.3 Birth to Infancy: The Supply Chain Critical Stage 104 5.4 Commercial Supply Under the Patent Protection Umbrella 111 5.5 What This Means for the Pharmaceutical Supply Chain 116 II BUILDING A KNOWLEDGE FOUNDATION IN SCM 125 6 Supply Chain Management as a Competitive Weapon 127 6.1 Competition and Business Strategy 127 6.2 The Marketing Mix 128 6.3 Porter's Five Forces 128 6.4 Porter's Generic Competitive Strategies 129 6.5 Porter's Value Chain 129 6.6 Competitive Strategy and Customers 133 6.7 The Japanese Experience 142 6.8 Total Quality Management 142 6.9 Lean Thinking 143 6.10 Focusing on Value for Money 146 6.11 SCM Processes in Competitive Strategy 148 6.12 SCM in Biotech and Virtual Companies 150 6.13 Competition in Pharmaceuticals 152 7 Supply Chain Management Holistic 155 7.1 The Relevance of SCM to Pharmaceuticals 155 7.2 Production Systems and the SCM Holistic 155 7.3 The Core of SCM 156 7.4 First Principle of SCM 156 7.5 Supply Chains as a Series of Interconnected Systems 158 7.6 Processes to Manage the Supply Chain 160 7.7 A Word About Processes 161 7.8 How the SCM Processes Should Mesh Together 163 7.9 Production and Inventory Control 163 7.10 Strategic Procurement 163 7.11 Transportation, Storage, and Distribution 164 7.12 Information Systems and Technology 164 7.13 Improvement 165 8 Production and Inventory Control 167 8.1 Core Mission 167 8.2 First Principles of Production and Inventory Control 167 8.3 The Wholesome Trinity in P&IC 174 8.4 The Wholesome Trinity and Customer Expectations 177 8.5 Leveraging the Wholesome Trinity 179 8.6 The Impact of Variety on Supply Chains 180 8.7 Designing Appropriate Production Systems 183 9 Strategic Procurement 187 9.1 Core Mission 187 9.2 The Purchasing Portfolio 188 9.3 The Process of Procurement 195 9.4 Strategic Sourcing and Planning 198 9.5 Outsourcing 201 9.6 Basic Principles in Contracting for Supply 206 9.7 Finally, Typical Organizational Tension over Procurement 213 10 Transportation, Storage, and Distribution 215 10.1 Defining the Core Mission 215 10.2 International Trade and Commerce 217 10.3 The World Trade Organization 217 10.4 Intermediary Arrangements 220 10.5 Terms of Trade: Incoterms 223 10.6 Ownership of Goods: Title 225 10.7 Third-Party Logistics Providers 226 10.8 Customs 227 10.9 Shipping Regulations Relating to Materials 229 10.10 A Finishing Note 230 11 Information Systems and Information Technology 233 11.1 Overview 233 11.2 Brief Lay History of Computer Systems Development 234 11.3 Important Perspectives on Information Systems 236 12 Improvement 255 12.1 Why Improve? 255 12.2 Improvement and Production Systems 257 12.3 The Improvement Journey 258 13 Bringing the Holistic Together 277 13.1 Setting the Scene 277 13.2 The Process Explained 278 13.3 Developing an Action Agenda 285 13.4 Case Study 289 III PLANNING AND EXECUTING SUPPLY CHAIN CHANGE 293 14 Improvement in Pharmaceuticals 295 14.1 Where Are We Now? 295 14.2 Subsequent Developments Since Inception 310 14.3 A Blueprint for Quality by Design 311 15 Exemplar Thinking in Organizational Improvement 335 15.1 Where Are We Now? 335 15.2 What Is Meant by "Exemplar"? 338 15.3 A Dialogue on Exemplar Improvement 338 15.4 An Approach to SCM Based on Systems Thinking 357 16 Building a Foundation for Sustainable Change 363 16.1 Focus on the Individual 363 16.2 Individuals as Leaders 368 16.3 Individuals as Motivators and the Motivated 370 16.4 Individuals as Group Members 372 16.5 Individuals as Participants in Cultural Change 376 16.6 Case Study: Miles Ltd., Bridgend, Glamorgan 378 17 A Cure for the Pharmaceutical Supply Chain 395 17.1 What Is the Disease State? 395 17.2 What Is the Label Claim for the Medicine? 396 17.3 What Will Life Hold Without the Medicine? 397 17.4 What Is This Better Way to Develop Drugs? 397 17.5 Full-Scale Production of Drugs 407 17.6 What Are the Barriers to Change? 410 17.7 What Are the Potential Benefits of Change? 413 17.8 Defining the Art of the Possible 414 17.9 Ending with the Beginning 417 END NOTES 419 INDEX 429
Rezensionen
"A recommended read for all wishing to shift performance to greater levels." (Supply Management, 1 February 2012)
"This book is ideal reading for those entering or currently working in the field of supply chain management, such as clinical supply managers, or those in operations or production and planning ... This book would be an excellent resource for small pharmaceutical companies that may have limited experience of supply chain implementation or outsourcing, giving a thorough overview of the process and plenty of food for thought." (The Pharmaceutical Journal, 16 November 2011)
"This is a solid text that is equally suitable for the newcomer or experienced profesional in the pharmaceutical/biologics industries . . . Overall, I recommend the book for its educational perspective on the industry and the significance of effective SCM for its future success." (Quality World, 1 July 2011)
"Hedley's interesting exploration of SCM issues includes business, control, regulatory and technical aspects. The book is salted with many personal experiences which keep the reader entertained as well as informed. This book is a must read for those entering into the SCM fields as well as all those who intersect with SCM." (Samedan Ltd, 4 February 2011)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497